Profile

Business Description

Pieris Pharmaceuticals, Inc. is a clinical-staged biotechnology company advancing its proprietary Anticalin® technology to create differentiated drugs that are safer and more effective than conventional approaches. Exclusive to Pieris, Anticalin proteins promise to address high-unmet medical needs and expand the potential of targeted therapeutics. The company currently has a diverse proprietary pipeline and has ongoing R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila, Stelis Biopharma and Allergan. Pieris has been funded by premier biotechnology-focused venture capital, including lead investors OrbiMed Advisors and Global Life Science Ventures.

Pieris Pharmaceuticals, Inc.

Fact Sheet

View our latest fact sheet

View Presentation

Company Info

Address:
255 State Street
9th floor
Boston, MA 02109 US

Telephone:
+49 (0) 8161 14 11 400

Fax:
+49 (0) 8161 14 11 444

Email:
info@pieris.com

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
541711 (Research and Development in Biotechnology)

SIC:
8731